Skip to main content
OpenTrials
Completed

NCT Number: NCT02962115

Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention

This study evaluates the feasibility of a clinical informatics system-based approach to lung cancer screening. Patients of a large academic medical center who may qualify for lung cancer screening will be sent an electronic invitation to complete an online lung cancer screening decision aid.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lung Neoplasms Lung Diseases Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

55 year–77 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The Center for Medicaid and Medicare Services (CMS) recently approved the use of low-dose chest CT scans for lung cancer screening in patients who meet specific criteria. However, many individuals who meet these criteria do not realize they qualify for screening. This study will determine the feasibility of using a clinical informatics approach to systematically identify potential candidates for LDCT screening, reach out to them via the patient portal, and use a web app to provide them with a personalized LDCT screening decision aid and facilitate the ordering of screening tests.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Has an active patient portal account
  • Scheduled to see a Wake Forest primary care provider within the next 4 weeks

Exclusion criteria

  • Never smokers
  • Current or former history of lung cancer
  • Receipt of chest CT scan within last 12 months
  • Need for a language interpreter
  • Presence of disease predicting short life-expectancy

Treatment and study plan

Decision Aid Invitation

Behavioral

electronic invitation to complete web-based decision aid

Primary outcomes

  1. Receipt of LDCT screening

    Time frame: 120 days

    Number of participants who received a low-dose chest CT

Secondary outcomes

  1. Read portal invitation

    Time frame: 120 days

    Number of participants who read the portal invitation

  2. Visit web decision aid

    Time frame: 120 days

    Number of participants who visited the study website

  3. Complete web decision aid

    Time frame: 120 days

    Number of participants who complete the lung cancer screening eligibility items

  4. Eligible for LDCT

    Time frame: 120 days

    Number of participants who are confirmed eligible for LDCT by the study website

  5. Interest in LDCT screening

    Time frame: 120 days

    Number of participants who indicate they are interested in receiving LDCT

  6. Appointment for LDCT visit

    Time frame: 120 days

    Number of participants who are scheduled for a lung cancer screening clinic visit or a LDCT exam

Sponsors and collaborators

Lead sponsor

Wake Forest University Health Sciences

Other

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Nov 11, 2016
Registry last updated
Feb 17, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.